Finance

Lists
Why is EPRX down 2,36%?
Dive Deeper
EPRX:TSE
Eupraxia Pharmaceuticals Inc
10,77 CA$
-2,36%
(-0,26) 1D
8 հոկ, 14:00:14 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
11,00 CA$
High
11,00 CA$
Low
10,44 CA$
Mkt. cap
700,25 մլն
Avg. vol.
86,07 հզր
Volume
22,42 հզր
52-wk high
13,08 CA$
52-wk low
7,35 CA$
EPS
-1,34 CA$
Beta
1,05
Shares outstanding
65,91 մլն
No. of employees
49
Open
11,00 CA$
High
11,00 CA$
Low
10,44 CA$
Mkt. cap
700,25 մլն
Avg. vol.
86,07 հզր
Volume
22,42 հզր
52-wk high
13,08 CA$
52-wk low
7,35 CA$
EPS
-1,34 CA$
Beta
1,05
Shares outstanding
65,91 մլն
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersՎիկտորիա, Բրիտանական Կոլումբիա, Կանադա
Sector-
Websiteeupraxiapharma.com
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,32 CA$ / -
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,42 մլն
7,87 մլն
11,17 մլն
12,81 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,47 մլն
8,30 մլն
4,78 մլն
5,30 մլն
Operating expense
6,88 մլն
16,16 մլն
15,96 մլն
18,10 մլն
Total operating expenses
6,88 մլն
16,16 մլն
15,96 մլն
18,10 մլն
Operating income
-6,88 մլն
-16,16 մլն
-15,96 մլն
-18,10 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-6,37 մլն
-16,71 մլն
-12,64 մլն
-14,46 մլն
EBT excluding unusual items
-6,37 մլն
-16,71 մլն
-12,64 մլն
-14,46 մլն
Income tax expense
-623,00
11,34 հզր
13,90 հզր
30,38 հզր
Effective tax rate
0,01%
-0,07%
-0,11%
-0,21%
Other operating expenses
-
-
-
-
Net income
-6,36 մլն
-16,71 մլն
-12,65 մլն
-14,49 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,19
-
-
-
Interest and investment income
180,18 հզր
666,92 հզր
1,07 մլն
1,39 մլն
Interest expense
-
-
-
-
Net interest expenses
180,18 հզր
666,92 հզր
1,07 մլն
1,39 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,84 մլն
-16,11 մլն
-15,90 մլն
-18,02 մլն
Gain or loss from assets sale
-
1,49 հզր
-
2,70 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps